Deep brain stimulation of the medial septum or nucleus accumbens alleviates psychosis-relevant behavior in ketamine-treated rats

Behavioural Brain Research

Volumn 266, Issue , 2014, Pages 174-182

  Ma, Jingyi ^a   Leung, L Stan ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Gamma waves; Hippocampal auditory evoked potentials; Medial septum; Nucleus accumbens; Prepulse inhibition

Indexed keywords

KETAMINE; AMINO ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY GATING; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; EXPERIMENTAL HYPERACTIVITY; GAMMA RHYTHM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; MEDIAL SEPTUM; NERVE CELL NETWORK; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; OUTCOME ASSESSMENT; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; RAT; SENSORY GATING; SEPTUM PELLUCIDUM; STRATUM RADIATUM; VALIDATION STUDY; ANALYSIS OF VARIANCE; ANIMAL; AUDITORY STIMULATION; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; LONG EVANS RAT; MOTOR ACTIVITY; PHYSIOLOGY; PROCEDURES; PSYCHOPHYSICS; PSYCHOTIC DISORDERS; SEPTUM NUCLEUS; STARTLE REFLEX; TOXICITY;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; DEEP BRAIN STIMULATION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PSYCHOACOUSTICS; PSYCHOTIC DISORDERS; RATS; RATS, LONG-EVANS; REFLEX, STARTLE; SEPTAL NUCLEI;

EID: 84897907383     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.03.010     Document Type: Article

References (76)

1. Amaral D.G., Kurz J. An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat. J Comp Neurol 1985, 240:37-59.
2. Anderson T., Hu B., Pittman Q., Kiss Z.H. Mechanisms of deep brain stimulation: an intracellular study in rat thalamus. J Physiol 2004, 559(Pt 1):301-313.
3. Andreasen N.C., Olsen S. Negative vs positive schizophrenia. Arch Gen Psychiatry 1982, 39:789-794.
4. Anis N.A., Berry S.C., Burton N.R., Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983, 79:565-575.
5. Baldeweg T., Spence S., Hirsch S., Gruzelier J. γ-band electroencephalographic oscillations in a patient with somatic hallucinations. Lancet 1998, 352:620-621.
6. Benabid A.L., Pollak P., Seigneuret E., Hoffmann D., Gay E., Perret J. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 1993, 58:39-44.
7. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
8. Bland B.H., Colom L.V. Extrinsic and intrinsic properties underlying oscillation and synchrony in limbic cortex. Prog Neurobiol 1993, 41:157-208.
9. Bland B.H., Oddie S.D. Theta band oscillation and synchrony in the hippocampal formation and associated structures: the case for its role in sensorimotor integration. Behav Brain Res 2001, 127:119-136.
10. Clementz B.A., Blumenfeld L.D., Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. Neuroreport 1997, 8:3889-3893.
11. Colom L.V., Castaneda M.T., Reyna T., Hernandes S. Characterization of medial septal glutamatergic neurons and their projection to the hippocampus. Synapse 2005, 58:151-164.
12. Ewing S.G., Grace A.A. Deep brain stimulation of the ventral hippocampus restores deficits in processing of auditory evoked potentials in a rodent developmental disruption model of schizophrenia. Schizophr Res 2013, 143:377-383.
13. Freund T.F., Antal M. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature 1988, 336:170-173.
14. Frotscher M., Leranth C. Cholinergic innervation of the rat hippocampaus as revealed by choline acetyltransferase immunocytochemistry: a combined light and electron microscopic study. J Comp Neurol 1985, 239:237-246.
15. Frush D.P., McNamara J.O. Evidence implicating dentate granule cells in wet dog shakes produced by kindling stimulations of entorhinal cortex. Exp Neurol 1986, 92:102-113.
16. Grossman S.P. An experimental 'dissection' of the septal syndrome. Functions of the septo-hippocampal system. Ciba foundation symposium 58 1978, 227-273. Elsevier, Amsterdam. K. Elliot, J. Whelan (Eds.).
17. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., et al. NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 1996, 16:2034-2043.
18. Haig A.R., Gordon E., De Pascalis V., Meares R.A., Bahramali H., Harris A. Gamma activity in schizophrenia: evidence of impaired network binding. Clin Neurophysiol 2000, 111:1461-1468.
19. Halberstadt A.L. The phencyclidine-glutamate model of schizophrenia. Clin Neuropharm 1995, 18:237-249.
20. Hakami T., Jones N.C., Tolmacheva E.A., Gaudias J., Chaumont J., Salzberg M., et al. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 2009, 4(8):e6755.
21. Hunt M.J., Raynaud B., Garcia R. Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats. Biol Psychiatry 2006, 60:1206-1214.
22. Hunt M.J., Falinska M., Łeski S., Wójcik D.K., Kasicki S. Differential effects produced by ketamine on oscillatory activity recorded in the rat hippocampus, dorsal striatum and nucleus accumbens. J Psychopharmacol 2011, 25:808-821.
23. Itil T.M., Itil K.Z. The significance of pharmacodynamic measures in the assessment of bioavailability and bioequivalence of psychotropic drugs using CEEG and dynamic brain mapping. J Clin Psychiatry 1986, 47:S20-S27.
24. Itil T.M., Marasa J., Saletu B., Davis S., Mucciardi A.N. Computerized EEG: predictor of outcome in schizophrenia. J Nerv Ment Dis 1975, 160:188-203.
25. Javitt D.C., Zukin S.R., Heresco-Levy U., Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr Bull 2012, 38:958-966.
26. Joyce J.N. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology 1993, 112:s16-s34.
27. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 1987, 13:261-276.
28. Kikuchi M., Hashimoto T., Nagasawa T., Hirosawa T., Minabe Y., Yoshimura M., et al. Frontal areas contribute to reduced global coordination of resting-state gamma activities in drug-naïve patients with schizophrenia. Schizophr Res 2011, 130:187-194.
29. Kittelberger K., Hur E.E., Sazegar S., Keshavan V., Kocsis B. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia. Brain Struct Funct 2012, 217:395-409.
30. Kiss J., Patel A.J., Freund T.F. Distribution of septohippocampal neurons containing parvalbumin or choline acetyltransferase in the rat brain. J Comp Neurol 1990, 298:362-372.
31. Kocsis B. Differential role of NR2A and NR2B subunits in N-methyl-d-aspartate receptor antagonist-induced aberrant cortical gamma oscillations. Biol Psychiatry 2012, 71:987-995.
32. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Arch Gen Psychiatry 1994, 51:199-214.
33. Lahti A.C., Holcomb H.H., Medoff D.R., Tamminga C.A. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 1995, 6:869-872.
34. Langsjo J.W., Maksimow A., Salmi E., Kaisti K., Aalto S., Oikonen V., et al. S-ketamine anesthesia increases cerebral blood flow in excess of the metabolic needs in humans. Anesthesiology 2005, 103:258-268.
35. Le Gal La Salle G., Cavalheiro E.A. Stimulation of septal and amygdaloid nuclei: EEG and behavioral responses during early development of kindling with special reference to wet dog shakes. Exp Neurol 1981, 74:717-727.
36. Leung L.S. Nonlinear feedback model of neuronal populations in hippocampal CA1 region. J Neurophysiol 1982, 47:848-868.
37. Leung L.S. Spectral analysis of hippocampal EEG in the freely moving rat: effects of centrally active drugs and relations to evoked potentials. Electroencephalogr Clin Neurophysiol 1985, 60:65-77.
38. Leung L.S. Generation of theta and gamma rhythms in the hippocampus. Neurosci Biobehav Rev 1998, 22:275-290.
39. Leung L.S., Shen B. Hippocampal partial kindling decreased hippocampal GABA-B receptor efficacy and wet dog shakes in behaving rats. Behav Brain Res 2006, 173:274-281.
40. Leung L.S., Lopes da Silva F.H., Wadman W.J. Spectral analysis of characteristics of the hippocampal EEG in the freely moving rat: effects of centrally active drugs and relations to evoked potentials. Electroencephalogr Clin Neurophysiol 1982, 54:203-219.
41. Lodge D.J., Behrens M.M., Grace A.A. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 2009, 29:2344-2354.
42. Ma J., Brudzynski S.M., Leung L.S. Involvement of the nucleus accumbens-ventral pallidal pathway in postictal behavior induced by a hippocampal after discharge in rats. Brain Res 1996, 739:26-35.
43. Ma J., Leung L.S. Medial septum mediates the increase in post-ictal behaviors and hippocampal gamma waves after an electrically induced seizure. Brain Res 1999, 833:51-57.
44. Ma J., Leung L.S. Relation between hippocampal (waves and behavioral disturbances induced by phencyclidine and methamphetamine. Behav Brain Res 2000, 111:1-11.
45. Ma J., Leung L.S. Limbic system participates in mediating the effects of general anesthetics. Neuropsychopharmacology 2006, 31:1177-1192.
46. Ma J., Leung L.S. The supramammillo-septal-hippocampal pathway mediates sensorimotor impairment and hyperlocomotion induced by MK-801 and ketamine in rats. Psychopharmacology 2007, 19:961-974.
47. Ma J., Shen B., Rajakumar N., Leung L.S. The medial septum mediates impairment of prepulse inhibition of acoustic startle induced by a hippocampal seizure or phencyclidine. Behav Brain Res 2004, 155:153-166.
48. Ma J., Tai S.K., Leung L.S. Ketamine-induced deficit of auditory gating in the hippocampus of rats is alleviated by medial septal inactivation and antipsychotic drugs. Psychopharmacology 2009, 206:457-467.
49. Ma J., Tai S.K., Leung L.S. Septohippocampal GABAergic neurons mediate the altered behaviors induced by N-methyl-d-aspartate receptor antagonists. Hippocampus 2012, 22:2208-2218.
50. McCracken C.B., Grace A.A. High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. J Neurosci 2007, 27:12601-12610.
51. McCracken C.B., Grace A.A. Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. J Neurosci 2009, 29:5354-5363.
52. McIntyre C.C., Grill W.M., Sherman D.L., Thakor N.V. Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J Neurophysiol 2004, 91:1457-1469.
53. Mikell C.B., McKhann G.M., Segal S., McGovern R.A., Wallenstein M.B., Moore H. The Hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia. Stereotact Funct Neurosurg 2009, 87:256-265.
54. Miller C.L., Freedman R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience 1995, 69:371-381.
55. Mogenson G.J., Brudzynski S.M., Wu M., Yang C.R., Yim C.C.Y. From motivation to action: a review of dopaminergic regulation of limbic-nucleus accumbens-ventral pallidum-pedunculopontine nucleus circuitries involved in limbic-motor integration. Limbic motor circuits and neuropsychiatry 1993, 193-225. CRC, Boca Raton, FL. P.W. Kalivas, C.D. Barnes (Eds.).
56. Moghaddam B., Krystal J.H. Capturing the angel in angel dust: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull 2012, 38:942-949.
57. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Ach Gen Psychiatry 1995, 52:998-1007.
58. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, Sydney, Australia. 6th ed.
59. Pinault D. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant (oscillations in the rat neocortex. Biol Psychiatry 2008, 63:730-735.
60. Racine R. Kindling: the first decade. Neurosurgery 1978, 3:234-250.
61. Ranck J.B. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res 1975, 98:417-440.
62. Rodriguez-Oroz M.C., Obeso J.A., Lang A.E., Houeto J.L., Pollak P., Rehncrona S., et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005, 128:2240-2249.
63. Saletu B., Itil T.M., Saletu M. Auditory evoked response, EEG, and thought process in schizophrenics. Am J Psychiatry 1971, 128:336-344.
64. Sartorius A., Kiening K.L., Kirsch P., von Gall C.C., Haberkorn U., Unterberg A.W., et al. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 2010, 15(67):e9-e11.
65. Schvarcz J.R. Long-term results of stimulation of the septal area for relief of neurogenic pain. Acta Neurochir Suppl (Wien) 1993, 58:154-155.
66. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702.
67. Spencer K.M., Nestor P.G., Niznikiewicz M.A., Salisbury D.F., Shenton M.E., McCarley R.W. Abnormal neural synchrony in schizophrenia. J Neurosci 2003, 23:7407-7411.
68. Sturm V., Lenartz D., Koulousakis A., Treuer H., Herholz K., Klein J.C., et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat 2003, 26:293-299.
69. Swerdlow N.R., Bakshi V., Waikar M., Taaid N., Geyer M.A. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology 1998, 140:75-80.
70. Swerdlow N.R., Geyer M.A. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res 1990, 532:46-150.
71. Symond M.P., Harris A.W., Gordon E., Williams L.M. Gamma synchrony in first-episode schizophrenia: a disorder of temporal connectivity. Am J Psychiatry 2005, 162:459-465.
72. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010, 11:100-113.
73. Ungerstedt U. Sterotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 1971, 82(Suppl. 367):1-48.
74. Vertes R.P., Kocsis B. Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience 1997, 81:893-926.
75. Walaas I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience 1980, 5:1691-1698.
76. Whittington M.A., Traub R.D., Jeffreys J.G. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 1995, 373:612-615.